GEODE CAPITAL MANAGEMENT, LLC - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 19 filers reported holding ALZAMEND NEURO INC in Q3 2021. The put-call ratio across all filers is 4.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q3 2023$150,775
-47.6%
636,010
+12.8%
0.00%
Q2 2023$287,466
+20.0%
563,6600.0%0.00%
Q1 2023$239,555
+75231.8%
563,6600.0%0.00%
Q4 2022$318
-99.9%
563,660
+7.2%
0.00%
Q3 2022$625,000
+1685.7%
525,750
+1195.4%
0.00%
Q2 2022$35,000
-28.6%
40,5870.0%0.00%
Q1 2022$49,000
-12.5%
40,587
+36.2%
0.00%
Q4 2021$56,000
-85.6%
29,791
-33.2%
0.00%
Q2 2021$389,00044,6000.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q3 2021
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders